Skye Bioscience Inc (SKYE)
11.99
-0.26
(-2.12%)
USD |
NASDAQ |
May 20, 11:16
Skye Bioscience Enterprise Value: 259.48M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 259.48M |
| May 16, 2024 | 265.10M |
| May 15, 2024 | 277.17M |
| May 14, 2024 | 262.29M |
| May 13, 2024 | 241.52M |
| May 10, 2024 | 238.99M |
| May 09, 2024 | 260.05M |
| May 08, 2024 | 272.05M |
| May 07, 2024 | 278.51M |
| May 06, 2024 | 283.84M |
| May 03, 2024 | 286.65M |
| May 02, 2024 | 285.80M |
| May 01, 2024 | 280.19M |
| April 30, 2024 | 284.12M |
| April 29, 2024 | 286.08M |
| April 26, 2024 | 286.08M |
| April 25, 2024 | 281.87M |
| April 24, 2024 | 281.87M |
| April 23, 2024 | 314.99M |
| April 22, 2024 | 336.88M |
| April 19, 2024 | 374.20M |
| April 18, 2024 | 397.49M |
| April 17, 2024 | 408.44M |
| April 16, 2024 | 377.29M |
| April 15, 2024 | 286.08M |
| Date | Value |
|---|---|
| April 12, 2024 | 283.56M |
| April 11, 2024 | 277.38M |
| April 10, 2024 | 280.75M |
| April 09, 2024 | 178.60M |
| April 08, 2024 | 190.39M |
| April 05, 2024 | 175.24M |
| April 04, 2024 | 232.20M |
| April 03, 2024 | 297.03M |
| April 02, 2024 | 316.95M |
| April 01, 2024 | 319.20M |
| March 28, 2024 | 442.02M |
| March 27, 2024 | 405.54M |
| March 26, 2024 | 389.54M |
| March 25, 2024 | 379.16M |
| March 22, 2024 | 339.87M |
| March 21, 2024 | 365.13M |
| March 20, 2024 | 358.25M |
| March 19, 2024 | 169.83M |
| March 18, 2024 | 169.83M |
| March 15, 2024 | 166.25M |
| March 14, 2024 | 162.42M |
| March 13, 2024 | 133.40M |
| March 12, 2024 | 132.16M |
| March 11, 2024 | 126.61M |
| March 08, 2024 | 167.67M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.584M
Minimum
Dec 11 2020
442.02M
Maximum
Mar 28 2024
37.56M
Average
21.20M
Median
Mar 17 2023
Enterprise Value Benchmarks
| Cutera Inc | 358.38M |
| Medical Marijuana Inc | 9.815M |
| OrthoPediatrics Corp | 725.56M |
| RAPT Therapeutics Inc | -0.5689M |
| NovaBay Pharmaceuticals Inc | 5.156M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.020M |
| Total Expenses (Quarterly) | 6.152M |
| EPS Diluted (Quarterly) | -0.18 |
| Earnings Yield | -37.60% |
| Normalized Earnings Yield | -3.914 |